Conectar
by Ika Saptarini, Sri Masyeni, Alida Roswita Harahap, Astuti Giantini, Pringgodigdo Nugroho, Agus Handito, Harimat Hendarwan, Adityo Susilo, Sotianingsih Haryanto, Desi Fitriani, R. Tedjo Sasmono, Erni Juwita Nelwan
BackgroundDengue virus (DENV) infection can manifest as dengue fever (DF) or dengue hemorrhagic fever (DHF), although DHF often becomes clinically apparent around defervescence. How complement components and other immune responses evolve over the course of illness from the febrile to recovery phase remains incompletely defined. This study characterized circulating complement activation and immune mediators in DF and DHF using paired febrile and early-recovery samples.
MethodsWe conducted a multicenter prospective cohort study at five hospitals in Indonesia between November 2024 and October 2025. Patients with laboratory-confirmed dengue were classified as DF or DHF. Plasma concentrations of PTX3, C5a, IL-6, IL-10, IL-8, and CXCL10 were quantified in paired febrile and early recovery phase samples. Between-group differences, within-patient changes between the two time points, and correlations among immune mediators were assessed using appropriate statistical methods.
ResultsWe included 110 confirmed dengue cases in the analysis. PTX3 and IL-10 levels were significantly higher in DHF than in DF during early recovery, whereas no mediator differed significantly between severity groups during the febrile phase. Across phases, C5a increased significantly from febrile to early recovery in DHF but not in DF, whereas PTX3 decreased significantly in DF but not in DHF. Correlations among mediators were generally weak to moderate, with a reproducible PTX3–IL-10–CXCL10 module observed across both phases.
ConclusionThe measured mediators did not distinguish DF from DHF during the febrile phase, but differences emerged in early recovery, with higher PTX3 and IL-10 in DHF. Across phases, C5a increased significantly from febrile to early recovery in DHF, whereas PTX3 decreased significantly only in DF. A PTX3–IL-10–CXCL10 module was observed at both time points. Together, these patterns suggest that within-patient changes around defervescence or in the early recovery may be informative and warrant evaluation in larger, prospectively timed cohorts.
Emotional and behavioural problems (EBPs) are receiving increasing attention at the global level, and preschool children are no exception. These issues have a significant impact on future development. Preventive interventions in preschool age are effective in preventing more serious disorders by improving social skills, emotional regulation and resilience in children. Although various preventive interventions have been developed and their effectiveness demonstrated, the evidence remains fragmented. At present, there has been no comprehensive study mapping EBPs prevention interventions at the preschool age level using the Neuman Systems Model approach.
This scoping review will be conducted in accordance with the Joanna Briggs Institute (JBI) methodology for scoping reviews.The completed scoping review will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR). A systematic search will be conducted in four major databases, namely Scopus, PubMed, Web of Science, Cochrane Library, and online searches using Google Scholar, without language and publication year restrictions. Two reviewers will independently screen the literature according to the inclusion criteria and then extract the data. Any differences between the two reviewers will be resolved through discussion with a third reviewer. We will compile, summarise and analyse the extracted data and present the results in figures, tables and descriptive narratives to ensure clarity and facilitate comparison across studies.
Ethical approval is not required, as the review will use only published literature. Findings will be disseminated through publication in a peer-reviewed international journal and may inform policy and practice in early childhood preventive interventions.
Open Science Framework (https://osf.io/zg6ty).
Smoking is a major global health problem. It kills more than half of the users. At least 1.18 billion people smoked cigarettes every day as of 2020. Although many interventions for tobacco smoking cessation have been implemented, their effectiveness remains unclear. This study aimed to assess the long-term effectiveness of various smoking cessation interventions in adults.
We conducted a systematic review and meta-analysis of randomized controlled trials reporting long-term outcomes.
Evidence searches were conducted in the Cochrane Library, Embase, Medline-OVID, PubMed, Web of Science, and Clinicaltrials.gov. Two researchers searched until August 2023 without restrictions on country, language, or year of publication. The risk ratio (RR) for continuous abstinence was obtained through biochemical verification at measurements ≥ 6 months post-intervention. Data were extracted and assessed for quality using Risk of Bias 2. Meta-analysis was carried out using a random effects model. Subgroup analyses and meta-regression were performed to explore moderator variables. Sensitivity and publication bias analyses were also performed.
Twenty-two effect sizes from 13 studies showed that tobacco smoking cessation interventions increased continuous abstinence by 2.5 times (RR 3.52; 95% CI; 2.19–5.65). The highest ratio was in the behavioral intervention (RR 7.83) with more than 6 months of therapy (RR 10.57). The tobacco smoking cessation intervention worked better in 55–64 years (RR 7.29), especially in Asia (RR 10.08). The intervention was more effective for female respondents (RR 4.21) and combination therapy format (RR 3.82). However, meta-regression showed that differences in gender and therapy format did not significantly influence the effectiveness of tobacco smoking cessation interventions in adults (p values 0.2748 and 0.8769). Sensitivity analysis (p-value 0.0025) further strengthens the evidence of the conclusions and credibility of the findings.
Behavioral therapy lasting more than 6 months was the most successful tobacco smoking cessation intervention in respondents aged 55–64 years, especially when implemented in Asia. Although not significant, therapies delivered in combination formats, especially in women, have the potential to increase continuous abstinence for adults. These findings provide important evidence for developing effective prevention and treatment strategies for long-term smoking cessation concerning the type, format, and total of therapy.
FreshRSS 